Guided Therapeutics (GTHP) Change in Account Payables (2011 - 2021)
Guided Therapeutics (GTHP) reported Change in Account Payables of -$84000.0 for Q2 2021, down 197.67% on a YoY basis from $86000.0 in Q2 2020, and down 389.66% sequentially from $29000.0 in Q1 2021.
Guided Therapeutics (GTHP) Change in Account Payables (2011 - 2021) Analysis & Trends
Guided Therapeutics (GTHP) has 11 years of Change in Account Payables data on file, last reported at -$84000.0 in Q2 2021.
- For the quarter ending Q2 2021, Change in Account Payables fell 197.67% year-over-year to -$84000.0; the trailing twelve-month figure through Jun 2021 stood at -$446000.0 (down 4560.0% YoY), and the FY2020 full-year result was -$372000.0, down 1960.0% from the prior year.
- Change in Account Payables fell to -$84000.0 in Q2 2021, from $29000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $148000.0 in Q1 2017 to a low of -$208000.0 in Q3 2020.
- A 5-year average of $388.89 and a median of $18500.0 in 2018 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 353.33% in 2019 and sank 730.3% in 2020, its largest moves.
- Tracing GTHP's Change in Account Payables over 5 years: stood at $54000.0 in 2017, then sank by 85.19% to $8000.0 in 2018, then slumped by 625.0% to -$42000.0 in 2019, then slumped by 335.71% to -$183000.0 in 2020, then soared by 54.1% to -$84000.0 in 2021.
- Business Quant data shows GTHP's Change in Account Payables at -$84000.0 in Q2 2021, $29000.0 in Q1 2021, and -$183000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -84,000.00 |
| Jun 30, 2021 | -84,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Mar 31, 2021 | 29,000.00 |
| Dec 31, 2020 | -183,000.00 |
| Dec 31, 2020 | -183,000.00 |
| Sep 30, 2020 | -208,000.00 |
| Sep 30, 2020 | -208,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Jun 30, 2020 | 86,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Dec 31, 2019 | -42,000.00 |
| Dec 31, 2019 | -42,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Sep 30, 2019 | 33,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Mar 31, 2019 | -9,000.00 |
| Mar 31, 2019 | -9,000.00 |